Our analysis revealed that HSD17B12 expression was significantly elevated in CRC tumor tissue (Fig 1A) (S1 Table), and this upregulation was associated with a favorable prognosis (Fig 1B) (S2 Table). This evidence concerns the gene HSD17B12 and neoplasm.